Upper Endoscopy in Cirrhotic Patients With Upper Gastrointestinal Bleeding

Launched by ASSIUT UNIVERSITY · Jan 17, 2024

Keywords

ClinConnect Summary

This clinical trial is investigating the use of upper endoscopy in patients who have liver cirrhosis and are experiencing upper gastrointestinal bleeding (UGIB). Liver cirrhosis is a serious condition where the liver becomes damaged, often leading to complications like bleeding from swollen blood vessels in the esophagus called varices. The goal of this study is to better understand how endoscopy can help manage this type of bleeding in patients with cirrhosis.

To participate in this trial, individuals must be at least 18 years old and have liver cirrhosis along with UGIB. Unfortunately, those under 18, those without cirrhosis, or those who are not stable enough to participate will not be eligible. If you qualify and choose to join, you can expect to undergo an upper endoscopy, a procedure that allows doctors to look inside the esophagus and stomach to identify the source of the bleeding. This study is not yet recruiting participants, but if you're interested or have questions, keep an eye out for updates!

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Any patient who is above age of 18 years old and with liver cirrhosis and present with UGIB will be eligible for the study
• Exclusion Criteria:
• • Patients with age less than 18 years old
• • Non-cirrhotic patients
• • Patients with hemodynamic instability
• • Patient's refusal